The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers
Abstract
Background: Eph receptors and their ligands, the ephrins, represent a large class of cell–cell communication molecules with well-defined developmental functions. Their role in healthy adult tissues and in human disease is still largely unknown, although diverse roles in carcinogenesis have been postulated. Methods: We established a set of fluorescent PCR probes and primers for the definition of individual gene expression profiles of 12 different Eph receptors and 8 ephrins in 13 different healthy tissues. The mRNA expression profiles were studied in human lung, colorectal, kidney, liver, and brain cancers. Results: The family of Eph receptors/ephrins was widely expressed in adult tissues with organ-site-specific patterns: EphB6 was highest in the thymus, compatible with an involvement in T-cell maturation. Brain and testis shared a unique pattern with EphA6, EphA8, and EphB1 being the most prominent. EphA7 had a high abundance in the kidney vasculature. Ephrin-A3 was up-regulated 26-fold in lung cancer, and EphB2 was up-regulated 9-fold in hepatocellular carcinoma. EphA8 was down-regulated in colon cancer, and EphA1/EphA8 was down-regulated in glioblastomas. Conclusion: Eph/Ephrin genes are widely expressed in all adult organs with certain organ-site-specific patterns. Because their function in adult tissues remains unknown, further analysis of their role in disease may disclose new insights beyond their well-defined meaning in development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems
Bustin, S. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290023 · Cited by 2,546
Batlle, E., Henderson, J. T., Beghtel, H., van den Born, M. M. W., Sancho, E., Huls, G., Meeldijk, J., Robertson, J., van de Wetering, M., Pawson, T., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01015-2 · Cited by 1,120
Unified Nomenclature for Eph Family Receptors and Their Ligands, the Ephrins
Eph Nomenclature Committee (1997) · Cell · doi:10.1016/s0092-8674(00)80500-0 · Cited by 432
Bubendorf, L., Nocito, A., Moch, H., & Sauter, G. (2001) · The Journal of Pathology · doi:10.1002/path.893 · Cited by 398
Crystal structure of an Eph receptor–ephrin complex
Himanen, J.-P., Rajashankar, K. R., Lackmann, M., Cowan, C. A., Henkemeyer, M., & Nikolov, D. B. (2001) · Nature · doi:10.1038/414933a · Cited by 339
The ephrins and Eph receptors in angiogenesis
Cheng, N., Brantley, D. M., & Chen, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00031-4 · Cited by 334
Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo
Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., Muraoka, R. S., Cerretti, D. P., Pozzi, A., Jackson, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205679 · Cited by 316
Overexpression of the EphA2 tyrosine kinase in prostate cancer
Walker-Daniels, J., Coffman, K., Azimi, M., Rhim, J. S., Bostwick, D. G., Snyder, P., Kerns, B. J., Waters, D. J., & Kinch, M. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19991201)41:4<275::aid-pros8>3.0.co;2-t · Cited by 269
Regulation and targets of receptor tyrosine kinases
Pawson, T. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80597-4 · Cited by 264
Langmann, T., Mauerer, R., Zahn, A., Moehle, C., Probst, M., Stremmel, W., & Schmitz, G. (2003) · Clinical Chemistry · doi:10.1373/49.2.230 · Cited by 259
Self-citationCheng, N., Brantley, D. M., Liu, H., Lin, Q., Enriquez, M., Gale, N., Yancopoulos, G. D., Cerretti, D. P., Daniel, T. O., & Chen, J. (2002) · PubMed · Cited by 255
Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner
Davy, A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5396 · Cited by 226
EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma
Miyazaki, T., Kato, H., Fukuchi, M., Nakajima, M., & Kuwano, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.10860 · Cited by 214
An Ephrin Mimetic Peptide That Selectively Targets the EphA2 Receptor
Koolpe, M., Dail, M., & Pasquale, E. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208495200 · Cited by 211
Pasquale, E. B. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80113-5 · Cited by 205
Bièche, I., Noguès, C., Paradis, V., Olivi, M., Bédossa, P., Lidereau, R., & Vidaud, M. (2000) · PubMed · Cited by 204
Molecular Cancer BioMed Central Molecular 12002, Cancer
Lynch, C. A., Tycko, B., Bestor, T. H., & Walsh, C. P. (2002) · Molecular Cancer · doi:10.1186/1476-4598-1-2 · Cited by 202
Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
Carles‐Kinch, K., Kilpatrick, K. E., Stewart, J. C., & Kinch, M. S. (2002) · PubMed · Cited by 195
Lawrenson, I. D., Wimmer-Kleikamp, S. H., Lock, P., Schoenwaelder, S. M., Down, M., Boyd, A. W., Alewood, P. F., & Lackmann, M. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.5.1059 · Cited by 169
Ephrin-B1 transduces signals to activate integrin-mediated migration,attachment and angiogenesis
Huynh-Do, U., Vindis, C., Liu, H., Cerretti, D. P., McGrew, J. T., Enriquez, M., Chen, J., & Daniel, T. O. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.15.3073 · Cited by 164
Ephrins and their Eph receptors: multitalented directors of embryonic development
Frisén, J., Holmberg, J., & Barbacid, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5159 · Cited by 151
Signaling by Eph receptors and their ephrin ligands
Brückner, K., & Klein, R. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80064-0 · Cited by 146
Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis
Nakamoto, M., & Bergemann, A. D. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10177 · Cited by 138
Up-regulation of ephrin-a1 during melanoma progression
Easty, D. J., Hill, S. P., Hsu, M., Fallowfield, M. E., Flørenes, V. A., Herlyn, M., & Bennett, D. C. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<494::aid-ijc8>3.0.co;2-o · Cited by 135
Prévost, N., Woulfe, D. S., Tanaka, T. I., & Brass, L. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142053899 · Cited by 130
Coexpression of ephrin‐Bs and their receptors in colon carcinoma
Liu, W., Ahmad, S. A., Jung, Y. D., Reinmuth, N., Fan Fan, B. S., Bucana, C. D., & Ellis, L. M. (2002) · Cancer · doi:10.1002/cncr.10122 · Cited by 126
Chiari, R., Hames, G., Stroobant, V., Texier, C., Maillère, B., Boon, T., & Coulie, P. G. (2000) · PubMed · Cited by 117
Oike, Y., Ito, Y., Hamada, K., Zhang, X., Miyata, K., Arai, F., Inada, T., Araki, K., Nakagata, N., Takeya, M., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1326.h81602001326_1326_1333 · Cited by 113
EphB6 crosslinking results in costimulation of T cells
Luo, H., Yu, G., Wu, Y., & Wu, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15883 · Cited by 77
EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity.
Lü, M., Miller, K. D., Gökmen‐Polar, Y., Jeng, M., & Kinch, M. S. (2003) · PubMed · Cited by 71
EphB6 crosslinking results in costimulation of T cells
Luo, H., Yu, G., Wu, Y., & Wu, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215883 · Cited by 64
Cited by
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Pasquale, E. B. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2806 · Cited by 1,226
Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., Basilion, J. P., Sedor, J., Wu, J., Danielpour, D., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.009 · Cited by 533
Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus
Bonaparte, M. I., Dimitrov, A. S., Bossart, K. N., Crameri, G., Mungall, B. A., Bishop, K. A., Choudhry, V., Dimitrov, D. S., Wang, L.-F., Eaton, B. T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504887102 · Cited by 479
The role of ephrins and Eph receptors in cancer
Surawska, H., Ma, P. C., & Salgia, R. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.09.002 · Cited by 341
The EphA2 Receptor and EphrinA1 Ligand in Solid Tumors: Function and Therapeutic Targeting
Wykosky, J., & Debinski, W. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0244 · Cited by 300
Metadata
- Authors
- Hafner, C., Schmitz, G., Meyer, S., Bataille, F., Hau, P., Langmann, T., Dietmaier, W., Landthaler, M., & Vogt, T.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-01
- Volume
- 50
- Issue
- 3
- Pages
- 490-499
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2105912939
- Cited by
- 323
- References
- 32
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.